Franklin FTSE South Korea ETF vs Liquidia Corporation Common Stock — how do they compare? Franklin FTSE South Korea ETF trades at $48.83 (market cap $1.67B), while Liquidia Corporation Common Stock trades at $33.5 (market cap $2.40B). The key difference: Liquidia Corporation Common Stock is the larger of the two by market cap, and Franklin FTSE South Korea ETF is trading nearer its 52-week high, Liquidia Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Franklin FTSE South Korea ETF for 15 Days and Liquidia Corporation Common Stock for 0 Days on average.
| FLKR | LQDA | |
|---|---|---|
Market Cap | $1.67B | $2.40B |
Volume | 703,703 | 2,857,547 |
Sector | Broad Market / Factor | Health |
52-Week High | $72.25 | $91.03 |
52-Week Low | $28.48 | $22.02 |
Typical Hold Time | 15 Days | 0 Days |
Enterprise Value | — | $2.30B |
Signals from Pluang's Aura AI — not financial advice
FLKR (Franklin FTSE South Korea ETF) is trading at $54.89, down 2.03% with a bearish technical signal (16 sell vs 6 buy signals). The ETF faces pressure from semiconductor sector volatility and rising global yields, though some analysts see current levels as a potential buying opportunity. Technical indicators show strong resistance at $55-$56 with support at $53-$54 levels. The fund remains heavily concentrated in Korean memory chip giants Samsung and SK Hynix, making it highly sensitive to AI and semiconductor cycles.
While FLKR faces near-term headwinds from semiconductor volatility and macroeconomic pressures, long-term prospects remain tied to AI-driven demand for Korean tech. The current discount to growth expectations presents opportunity, but investors must weigh concentration risk against potential semiconductor recovery. Key risks include political tensions, currency fluctuations, and global interest rate environment.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Franklin FTSE South Korea ETF seeks to track an index of South Korean equities. The fund provides exposure to companies listed in South Korea across multiple sectors.
Read more on FLKR →Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →